- Trials with a EudraCT protocol (6)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
6 result(s) found for: Hypnosis.
Displaying page 1 of 1.
EudraCT Number: 2010-019591-67 | Sponsor Protocol Number: 1008032 | Start Date*: 2010-06-01 | |||||||||||
Sponsor Name:CHU de SAINT-ETIENNE | |||||||||||||
Full Title: Pain assessment during general anesthesia : DOLANS Study | |||||||||||||
Medical condition: perioperative analgesia | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-004132-20 | Sponsor Protocol Number: ALS-8-08-A-401 | Start Date*: 2008-11-07 |
Sponsor Name:Air Liquide Santé International | ||
Full Title: This protocol describes a total of three studies that are intrinsically linked. It does therefore have three titels. 1. The effect of xenon and sevoflurane on depth of hypnosis monitors when titrat... | ||
Medical condition: 1. The effect of xenon and sevoflurane on depth of hypnosis monitors when titrated to standard anesthesia parameter. 2. The efficacy of dexamethasone for prevention of PONV after xenon or sevoflura... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2006-001174-25 | Sponsor Protocol Number: PROREMI | Start Date*: 2006-03-13 | |||||||||||
Sponsor Name:OSPEDALE S. RAFFAELE | |||||||||||||
Full Title: EFFECT OF REMIFENTANIL AND PRPOPOFOL TIMING ADMINISTRATION ON THE DEEPNESS OF HYPNOSIS. | |||||||||||||
Medical condition: PATIENTS UNDERGOING SURGERY WITH LOCOREGIONAL ANAESTHESIA AND SEDATION | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-004193-27 | Sponsor Protocol Number: NEU 112006 | Start Date*: 2006-09-26 |
Sponsor Name:Neurim Pharmaceuticals (1991) Ltd | ||
Full Title: A Double Blind, Parallel Group, Randomised, Placebo Controlled Study of Efficacy and Safety of CIRCADIN 2mg in the Treatment of Insomnia Patients with Low Endogenous Melatonin. | ||
Medical condition: Primary insomnia in adults with low endegenous melatonin. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-006488-22 | Sponsor Protocol Number: E2007-G000-227 | Start Date*: 2007-10-03 | |||||||||||
Sponsor Name:Eisai Limited | |||||||||||||
Full Title: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel- Group Trial to Evaluate the Efficacy and Safety of E2007 in Patients with Painful Diabetic Neuropathy | |||||||||||||
Medical condition: Painful Diabetic Neuropathy | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) LT (Completed) DE (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-004833-25 | Sponsor Protocol Number: UNLOCK | Start Date*: 2017-03-29 |
Sponsor Name:Consorci Mar Parc de Salut de Barcelona (Parc de Salut Mar) | ||
Full Title: Synchronous effect of anesthetics on fMRI, EEG and clinical responses. Development of a more precise system for monitoring anesthetic effect. | ||
Medical condition: General anaesthesia in healthy subjects | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
